Chen Juyu, the founder and chairman of Shenyang Xiehe Group Co., Ltd., guest professor in the Faculty of Biology in Liaoling University, entrepreneur and philanthropist. Based on his profound technical knowledge, Chen Juyu followed closely the forefront of technology in the world pharmaceutical drugs. Availing of the superantigen theory and clinical researches of American and European scientists, Chen Juyu headed his researchers and cultured their own proprietary superantigen strains. Highly Agglutinative Staphylococcin (HAS), a Class 2 new drug in biological preparations, was successfully developed. In 1999, HAS was approved by Chinese FDA and applied clinically.    

Because of the outstanding achievements made by Chairman Chen Juyu in developing drugs against cancer and AIDS, exemplary contributions in worldwide charity, he was awarded by Chinese Ministry of Science, Shenyang Municipal Government and charity institutions in different countries. Hereunder is a brief list of honors and awards given to him.
         1998- 2001  Brilliant Scientific Entrepreneur awarded by Liaoning Province and Shenyang City

  2000      received Liaoning Science Revitalization Award

  2001      received Pioneer Award for Chinese Private Entrepreneurs

  2005      conferred with knighthood by the Order of Saint John

  2007      promoted to “Grand Master of Saint Johe” by the Order of Saint John

  2013      conferred with dukedom by S.I.T.O of Germany